Atlas Trials

Transcutaneous Supraorbital Nerve Stimulator Versus Topiramate in Prevention of Recurrent Migraine

Clinical trial NCT05516251 · UNKNOWN

Trial details

NCT number
NCT05516251
Sponsor
Tongji Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Migraine, Classic
Start date
2021-10-01
Primary completion
2023-04-30
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.